当前位置: X-MOL 学术J. Surg. Oncol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Should adenosquamous esophageal cancer be treated like adenocarcinoma or squamous cell carcinoma?
Journal of Surgical Oncology ( IF 2.5 ) Pub Date : 2020-05-27 , DOI: 10.1002/jso.25990
Adriana C Gamboa 1 , Benjamin I Meyer 1 , Jeffrey M Switchenko 2 , Manali Rupji 2 , Rachel M Lee 1 , Michael K Turgeon 1 , Maria C Russell 1 , Kenneth Cardona 1 , David A Kooby 1 , Shishir K Maithel 1 , Mihir M Shah 1
Affiliation  

Esophageal adenocarcinoma (AC) and squamous cell carcinoma (SCC) have distinct outcomes, treatment strategies, and response profiles to therapy. Adenosquamous carcinoma (ASC) is thought to behave more aggressively than each of its counterparts. The aim of this study is to determine ifASC is best managed as AC or SCC.

中文翻译:

食道腺鳞癌应该像腺癌或鳞状细胞癌一样对待吗?

食道腺癌(AC)和鳞状细胞癌(SCC)具有不同的结局,治疗策略和对治疗的反应情况。腺鳞癌(ASC)的行为被认为比每个对应的癌都更具侵略性。这项研究的目的是确定ASC最佳管理为AC还是SCC。
更新日期:2020-08-01
down
wechat
bug